Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society.

Autor: Pimentel MA; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA., Li MM, Noe MH, Latour E, Seminario-Vidal L, Greiling T; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA., Shinkai K, Hamilton A, Alavi A, Bolognia JL, Cowen EW, Dominguez A, Fernandez AP, Fivenson D, Huang WW, Madigan LM, Mauskar M, Means AD, Nelson CA, Patsatsi A, Pugliese D, Rojek NW, Rosenbach M, Smith GP, Swerlick RA, Heffernan MP, Mostaghimi A, Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2023 Mar 30; Vol. 188 (4), pp. 566-568.

Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis.

Autor: Değirmenci, Mehmet Fatih Kağan¹ mfkdegirmenci@ankara.edu.tr, Yalçındağ, Fatime Nilüfer²

Publikováno v: Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi. Apr2024, Vol. 54 Issue 2, p112-115. 4p.

A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis.

Autor: Jiang, Yuxiong^1,2 (AUTHOR), Huang, Dawei^1,2 (AUTHOR), Chen, Qianyu^1,2 (AUTHOR), Yu, Yingyuan^1,2 (AUTHOR), Hu, Yifan^1,2 (AUTHOR), Wang, Yu^1,2 (AUTHOR), Chen, Rongfen^1,2 (AUTHOR), Yao, Lingling^1,2 (AUTHOR), Zhong, Xiaoyuan^1,2 (AUTHOR), Kong, Luyang^1,2 (AUTHOR), Yu, Qian^2,3 (AUTHOR), Lu, Jiajing^1,2 (AUTHOR) bonnie166166@126.com, Li, Ying^1,2 (AUTHOR) liying631116@163.com, Shi, Yuling^1,2 (AUTHOR) shiyuling1973@tongji.edu.cn

Publikováno v: Journal of Translational Medicine. 1/31/2024, Vol. 22, p1-13. 13p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution.

Autor: Muram TM; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. Electronic address: muram_talia_m@lilly.com., Sloan JH; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Chain JS; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Komocsar WJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Meiklejohn BI; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Blauvelt A; Oregon Medical Research Center, Portland, Oregon, USA., Papp K; Probity Medical Research, Waterloo, Ontario, Canada., Heffernan MP; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Qian YW; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Konrad RJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2016 Jul; Vol. 136 (7), pp. 1513-1515. Date of Electronic Publication: 2016 Mar 30.